<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 19 Nov 2026 14:15:51 -0500--><rss version="2.0">
    <channel>
        <title>Capricor Therapeutics, Inc. (CAPR) Press Releases</title>
        <link>https://www.capricor.com/investors/news-events/press-releases/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/capricor/files/theme/images/logo-sm.png</url>
                <title>Capricor Therapeutics, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Capricor Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/359/capricor-therapeutics-reports-third-quarter-2026-financial</link>
                <pubDate>Tue, 10 Nov 26 16:05:00 -0500</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/359/capricor-therapeutics-reports-third-quarter-2026-financial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/358/capricors-hope-3-phase-3-cardiac-results-for-deramiocel</link>
                <pubDate>Mon, 09 Nov 26 09:00:00 -0500</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/358/capricors-hope-3-phase-3-cardiac-results-for-deramiocel</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Capricor Therapeutics to Report Third Quarter 2026 Financial Results and Provide Recent Corporate Update on November 10]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/357/capricor-therapeutics-to-report-third-quarter-2026</link>
                <pubDate>Tue, 03 Nov 26 09:00:00 -0500</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/357/capricor-therapeutics-to-report-third-quarter-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data on Upper Limb Function in Duchenne Muscular Dystrophy at 2026 World Muscle Society Congress]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/356/capricor-therapeutics-presents-positive-hope-3-open-label</link>
                <pubDate>Mon, 05 Oct 26 09:00:00 -0400</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/356/capricor-therapeutics-presents-positive-hope-3-open-label</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/355/capricor-therapeutics-to-present-hope-3-and-hope-3</link>
                <pubDate>Thu, 17 Sep 26 08:30:00 -0400</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/355/capricor-therapeutics-to-present-hope-3-and-hope-3</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/354/capricor-therapeutics-announces-extension-of-pdufa-target</link>
                <pubDate>Mon, 24 Aug 26 09:25:00 -0400</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/354/capricor-therapeutics-announces-extension-of-pdufa-target</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/353/capricor-therapeutics-reports-second-quarter-2026-financial</link>
                <pubDate>Thu, 13 Aug 26 16:05:00 -0400</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/353/capricor-therapeutics-reports-second-quarter-2026-financial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/352/capricor-therapeutics-to-report-second-quarter-2026</link>
                <pubDate>Mon, 10 Aug 26 08:30:00 -0400</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/352/capricor-therapeutics-to-report-second-quarter-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/351/capricor-therapeutics-provides-update-on-fda-advisory</link>
                <pubDate>Thu, 30 Jul 26 09:30:00 -0400</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/351/capricor-therapeutics-provides-update-on-fda-advisory</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.capricor.com/investors/news-events/press-releases/detail/350/the-lancet-publishes-hope-3-data-for-capricor</link>
                <pubDate>Wed, 29 Jul 26 10:05:00 -0400</pubDate>
                <guid>https://www.capricor.com/investors/news-events/press-releases/detail/350/the-lancet-publishes-hope-3-data-for-capricor</guid>
                                                                            </item>
            </channel>
</rss>